U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07014189) titled 'Nevirapine / Lamivudine for HIV Maintenance Therapy' on June 02.
Brief Summary: The standard treatment for HIV infection involves taking a combination of three HIV drugs. The main reason for using multiple substances is to prevent resistance from developing rapidly when only one or two drugs are used.
However, in recent years, studies have shown that the risk of resistance developing is significantly lower once viral replication in the body has been completely suppressed. Studies have now been conducted on this maintenance therapy phase, which aims to reduce the number of drugs used.
Some positive results have been reported with m...